Mirum Pharmaceuticals CEO Christopher Peetz's 2023 pay jumps 47% to $6.5M
Mirum Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 23, 2024
Mirum Pharmaceuticals reported fiscal year 2023 executive compensation information on April 23, 2024.
In 2023, three executives at Mirum Pharmaceuticals received on average a compensation package of $4.4M, a 95% increase compared to previous year.
Average pay of disclosed executives at Mirum Pharmaceuticals
Christopher Peetz, Chief Executive Officer, received $6.5M in total, which increased by 47% compared to 2022. 52% of Peetz's compensation, or $3.4M, was in option awards. Peetz also received $634K in non-equity incentive plan, $660K in salary, $1.8M in stock awards, as well as $13K in other compensation.
Eric Bjerkholt, Chief Financial Officer, received a compensation package of $4.3M. 56% of the compensation package, or $2.4M, was in option awards.
Peter Radovich, Chief Operating Officer, earned $2.4M in 2023, a 52% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 23, 2024.